Education
About Us
Working with TipRanks
Follow Us
CureVac (CVAC)
NASDAQ:CVAC
Total Valuation
CureVac has a market cap or net worth of $736.26M. The enterprise value is $306.49M.
Market Cap$736.26M
Enterprise Value$306.49M
Share Statistics
CureVac has 225,155,870 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding225,155,870
Owned by Insiders―
Owned by Institutions0.01%
Financial Efficiency
CureVac’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee65.16K
Profits Per Employee-315.35K
Employee Count825
Asset Turnover0.07
Inventory Turnover5.01
Valuation Ratios
The current PE Ratio of CureVac is -3.23. CureVac’s PEG ratio is 0.30.
PE Ratio-3.23
PS Ratio26.28
PB Ratio1.62
Price to Fair Value1.62
Price to FCF-2.60
Price to Operating Cash Flow-3.13
PEG Ratio0.30
Income Statement
In the last 12 months, CureVac had revenue of 53.76M and earned -260.17M in profits. Earnings per share was -1.18.
Revenue53.76M
Gross Profit-70.61M
Operating Income-274.21M
Pretax Income-259.97M
Net Income-260.17M
EBITDA-234.09M
Earnings Per Share (EPS)-1.18
Cash Flow
In the last 12 months, operating cash flow was 128.45M and capital expenditures -29.45M, giving a free cash flow of 99.35M billion.
Operating Cash Flow128.45M
Free Cash Flow99.35M
Free Cash Flow per Share0.44
Dividends & Yields
CureVac pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.15
52-Week Price Change8.63%
50-Day Moving Average3.07
200-Day Moving Average3.20
Relative Strength Index (RSI)58.57
Average Volume (3m)656.07K
Important Dates
CureVac upcoming earnings date is May 21, 2025, TBA Not Confirmed.
Last Earnings DateApr 10, 2025
Next Earnings DateMay 21, 2025
Ex-Dividend Date―
Financial Position
CureVac as a current ratio of 2.57, with Debt / Equity ratio of 5.54%
Current Ratio2.57
Quick Ratio2.43
Debt to Market Cap0.00
Net Debt to EBITDA―
Interest Coverage Ratio-109.99
Taxes
In the past 12 months, CureVac has paid 198.00K in taxes.
Income Tax198.00K
Effective Tax Rate>-0.01
Enterprise Valuation
CureVac EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
CureVac has $554.92M in cash and marketable securities with €0.00 in debt, giving a net cash position of -$514.79M billion.
Cash & Marketable Securities$554.92M
Total Debt€0.00
Net Cash-$514.79M
Net Cash Per Share-$2.29
Tangible Book Value Per Share$2.22
Margins
Gross margin is 69.76%, with operating margin of -510.08%, and net profit margin of -483.96%.
Gross Margin69.76%
Operating Margin-510.08%
Pretax Margin-483.59%
Net Profit Margin-483.96%
EBITDA Margin-435.45%
EBIT Margin-478.95%
Analyst Forecast
The average price target for CureVac is $6.88, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$6.88
Price Target Upside102.35% Upside
Analyst ConsensusHold
Analyst Count4
Revenue Growth Forecast910.33%
EPS Growth Forecast―